Treatment Outcomes of Third-Line Antiretroviral Regimens in HIV-Infected Thai Adolescents.

Prasitsuebsai, Wasana; Sophonphan, Jiratchaya; Chokephaibulkit, Kulkanya; More

Pediatric Infectious Disease Journal ., Post Acceptance: May 16, 2017

Noncirrhotic Portal Hypertension in Perinatally HIV-infected Adolescents Treated With Didanosine-containing Antiretroviral Regimens in Childhood

Scherpbier, Henriette J.; Terpstra, Valeska; Pajkrt, Dasja; More

Pediatric Infectious Disease Journal . 35(8):e248-e252, August 2016.

Brain Imaging and Neurodevelopment in HIV-uninfected Thai Children Born to HIV-infected Mothers

Jahanshad, Neda; Couture, Marie-Claude; Prasitsuebsai, Wasana; More

Pediatric Infectious Disease Journal . 34(9):e211-e216, September 2015.

Risk of First-line Antiretroviral Therapy Failure in HIV-infected Thai Children and Adolescents

Bunupuradah, Torsak; Sricharoenchai, Sirintip; Hansudewechakul, Rawiwan; More

Pediatric Infectious Disease Journal . 34(3):e58-e62, March 2015.

Pharmacokinetics of Atazanavir/Ritonavir Among HIV-infected Thai Children Concomitantly Taking Tenofovir Disoproxil Fumarate

Bunupuradah, Torsak; Techasaensiri, Chonnamet; Keadpudsa, Siriwan; More

Pediatric Infectious Disease Journal . 33(12):e316-e319, December 2014.

Cognitive Function and Neurodevelopmental Outcomes in HIV-infected Children Older Than 1 Year of Age Randomized to Early Versus Deferred Antiretroviral Therapy: The PREDICT...

Puthanakit, Thanyawee; Ananworanich, Jintanat; Vonthanak, Saphonn; More

Pediatric Infectious Disease Journal . 32(5):501-508, May 2013.

Long-term Lopinavir/Ritonavir Monotherapy in HIV-infected Children

Kosalaraksa, Pope; Ananworanich, Jintanat; Puthanakit, Thanyawee; More

Pediatric Infectious Disease Journal . 32(4):350-353, April 2013.

Prevalence of Human Leukocyte Antigen-B*5701 Among HIV-infected Children in Thailand and Cambodia: Implications for Abacavir Use

Puthanakit, Thanyawee; Bunupuradah, Torsak; Kosalaraksa, Pope; More

Pediatric Infectious Disease Journal . 32(3):252-253, March 2013.

CD4 CELL COUNT CRITERIA TO DETERMINE WHEN TO INITIATE ANTIRETROVIRAL THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN

Wongsawat, Jurai; Puthanakit, Thanyawee; Kanjanavanit, Suparat; More

Pediatric Infectious Disease Journal . 29(10):966-968, October 2010.

Pattern and Predictors of Immunologic Recovery in Human Immunodeficiency Virus-Infected Children Receiving Non-Nucleoside Reverse Transcriptase Inhibitor-Based Highly Active...

Puthanakit, Thanyawee; Kerr, Stephen J.; Ananworanich, Jintanat; More

Pediatric Infectious Disease Journal . 28(6):488-492, June 2009.

Double Boosted Protease Inhibitors, Saquinavir, and Lopinavir/Ritonavir, in Nucleoside Pretreated Children at 48 Weeks

Kosalaraksa, Pope; Bunupuradah, Torsak; Engchanil, Chulapan; More

Pediatric Infectious Disease Journal . 27(7):623-628, July 2008.

Pharmacokinetics and 24-Week Efficacy/Safety of Dual Boosted Saquinavir/Lopinavir/Ritonavir in Nucleoside-Pretreated Children

Ananworanich, Jintanat; Kosalaraksa, Pope; Hill, Andrew; More

Pediatric Infectious Disease Journal . 24(10):874-879, October 2005.